A Nomogram Based on Apelin-12 for the Prediction of Major Adverse Cardiovascular Events after Percutaneous Coronary Intervention among Patients with ST-Segment Elevation Myocardial Infarction

Figure 5

Decision curve analysis of apelin-12 based nomogram and other already available risk scores in terms of major adverse cardiovascular events risk in the whole cohort. The X-axis represents the threshold probability. The Y-axis measures the net benefit. The red line illustrates the major adverse cardiovascular events risk nomogram. The threshold probability is where the expected benefit of treatment balances the expected benefit of avoiding treatment.